Quarterly Balance Sheet

Oncolys BioPharma Inc. - Filing #7723173

Concept As at
2018-06-30
As at
2017-12-31
Quarterly balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
1,852,162,000 JPY
2,867,512,000 JPY
Work in process
5,137,000 JPY
4,931,000 JPY
Other
151,000 JPY
285,000 JPY
Current assets
1,998,004,000 JPY
3,071,713,000 JPY
Non-current assets
Property, plant and equipment
2,714,000 JPY
2,506,000 JPY
Property, plant and equipment
Buildings
2,794,000 JPY
2,794,000 JPY
Accumulated depreciation
-2,794,000 JPY
-2,794,000 JPY
Buildings, net
JPY
JPY
Tools, furniture and fixtures
68,259,000 JPY
67,313,000 JPY
Accumulated depreciation
-65,544,000 JPY
-64,807,000 JPY
Tools, furniture and fixtures, net
2,714,000 JPY
2,506,000 JPY
Investments and other assets
807,732,000 JPY
452,002,000 JPY
Investments and other assets
Investment securities
665,614,000 JPY
400,194,000 JPY
Shares of subsidiaries and associates
101,153,000 JPY
10,173,000 JPY
Investments in capital
100,000 JPY
100,000 JPY
Long-term loans receivable from subsidiaries and associates
11,045,000 JPY
11,079,000 JPY
Long-term prepaid expenses
1,044,000 JPY
1,223,000 JPY
Other
19,000 JPY
19,000 JPY
Non-current assets
810,446,000 JPY
454,508,000 JPY
Assets
2,808,451,000 JPY
3,526,222,000 JPY
Liabilities
Current liabilities
Short-term borrowings
83,336,000 JPY
93,336,000 JPY
Income taxes payable
26,036,000 JPY
32,826,000 JPY
Current liabilities
183,698,000 JPY
239,035,000 JPY
Non-current liabilities
Long-term borrowings
327,772,000 JPY
344,440,000 JPY
Non-current liabilities
334,590,000 JPY
355,293,000 JPY
Liabilities
518,289,000 JPY
594,328,000 JPY
Net assets
Shareholders' equity
Share capital
5,802,444,000 JPY
5,802,444,000 JPY
Capital surplus
5,794,944,000 JPY
5,794,944,000 JPY
Retained earnings
-9,301,839,000 JPY
-8,660,016,000 JPY
Shareholders' equity
2,295,548,000 JPY
2,937,371,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
-15,696,000 JPY
-15,786,000 JPY
Valuation and translation adjustments
-15,696,000 JPY
-15,786,000 JPY
Share acquisition rights
10,309,000 JPY
10,309,000 JPY
Net assets
2,290,161,000 JPY
2,931,893,000 JPY
Liabilities and net assets
2,808,451,000 JPY
3,526,222,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.